Alterity Therapeutics (PRNAD) Total Current Liabilities (2009 - 2025)

Alterity Therapeutics (PRNAD) has reported Total Current Liabilities for 16 consecutive years, with $1.7 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Total Current Liabilities fell 4.49% year-over-year to $1.7 million; the TTM figure through Dec 2025 stood at $1.7 million (down 4.49% YoY), while the FY2025 annual figure was $2.3 million, down 36.08% from the prior year.
• Total Current Liabilities came in at $1.7 million for Q4 2025 at Alterity Therapeutics, down from $2.3 million in the prior quarter.
• The five-year high for Total Current Liabilities was $4.2 million in Q2 2022, with the low at -$5.1 million in Q2 2024.
• Average Total Current Liabilities over 5 years is $1.6 million, with a median of $2.3 million recorded in 2025.
• Across the five-year window, Total Current Liabilities slumped 11742.89% in 2024 and surged 144.37% in 2025, its largest moves.
• Year by year, Total Current Liabilities stood at $2.7 million in 2021, then gained by 25.41% to $3.4 million in 2022, then fell by 14.91% to $2.9 million in 2023, then tumbled by 39.23% to $1.8 million in 2024, then slipped by 4.49% to $1.7 million in 2025.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $1.7 million, $2.3 million, and $1.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.